MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression

Journal of Cellular Biochemistry

Volumn 113, Issue 6, 2012, Pages 2040-2046

  Wang, Changxin ^a   Wang, Shuiyun ^a   Zhao, Peng ^b   Wang, Xiaojian ^a   Wang, Jizheng ^a   Wang, Yilu ^a   Song, Lei ^a   Zou, Yubao ^a   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

CARDIAC HYPERTROPHY; microRNA; miR 221; p27

Indexed keywords

MICRORNA; MIR 221; PROTEIN P27; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; CARDIOMEGALY; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HEART VENTRICLES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; RNA, MESSENGER;

MUS;

EID: 84859564908     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24075     Document Type: Article

References (34)

1. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE,. 2005. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122: 553-563.
2. Barrick CJ, Rojas M, Schoonhoven R, Smyth SS, Threadgill DW,. 2007. Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: Temporal- and background-dependent development of concentric left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 292: H2119-H2130.
3. Bartel DP,. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
4. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang DZ,. 2009. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119: 2772-2786.
5. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Hoydal M, Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G,. 2007. MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618.
6. Chen J, Yang T, Yu H, Sun K, Shi Y, Song W, Bai Y, Wang X, Lou K, Song Y, Zhang Y, Hui R,. 2010. A functional variant in the 3′-UTR of angiopoietin-1 might reduce stroke risk by interfering with the binding efficiency of microRNA 211. Hum Mol Genet 19: 2524-2533.
7. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C,. 2007. MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy? Am J Pathol 170: 1831-1840.
8. da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, van der Nagel R, van Kuik J, de Weger R, de Bruin A, Condorelli G, Arbones ML, Eschenhagen T, De Windt LJ,. 2010. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 12: 1220-1227.
9. Frey N, Olson EN,. 2003. Cardiac hypertrophy: The good, the bad, and the ugly. Annu Rev Physiol 65: 45-79.
10. Hauck L, Harms C, An J, Rohne J, Gertz K, Dietz R, Endres M, von Harsdorf R,. 2008. Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart. Nat Med 14: 315-324.
11. Heineke J, Molkentin JD,. 2006. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7: 589-600.
12. Hua Y, Zhang Y, Ren J,. 2012. IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: Role of microRNA-1 and microRNA-133a. J Cell Mol Med 16: 83-95.
13. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP,. 1990. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566.
14. Li JM, Brooks G,. 1997. Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in press ure-overload hypertrophy. Am J Physiol 273: H1358-H1367.
15. Li Q, Lin X, Yang X, Chang J,. 2010. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. Am J Physiol Heart Circ Physiol 298: H1340-H1347.
16. Lin Z, Murtaza I, Wang K, Jiao J, Gao J, Li PF,. 2009. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci USA 106: 12103-12108.
17. Liu ZP, Olson EN,. 2002. Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase. Proc Natl Acad Sci USA 99: 2043-2048.
18. Maron BJ,. 2002. Hypertrophic cardiomyopathy: A systematic review. JAMA 287: 1308-1320.
19. Mudd JO, Kass DA,. 2008. Tackling heart failure in the twenty-first century. Nature 451: 919-928.
20. Olson EN,. 2004. A decade of discoveries in cardiac biology. Nat Med 10: 467-474.
21. Patten RD, Hall-Porter MR,. 2009. Small animal models of heart failure: Development of novel therapies, past and present. Circ Heart Fail 2: 138-144.
22. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR,. 1991. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88: 8277-8281.
23. Rohini A, Agrawal N, Koyani CN, Singh R,. 2010. Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res 61: 269-280.
24. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M,. 2007. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416-424.
25. Schmittgen TD, Livak KJ,. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
26. Shieh JT, Huang Y, Gilmore J, Srivastava D,. 2011. Elevated miR-499 levels blunt the cardiac stress response. PLoS One 6: e19481.
27. Siedlecki AM, Jin X, Muslin AJ,. 2009. Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure. Kidney Int 75: 800-808.
28. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, Rojas M, Hammond SM, Wang DZ,. 2007. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42: 1137-1141.
29. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN,. 2007. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579.
30. Wang K, Long B, Zhou J, Li PF,. 2010. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. J Biol Chem 285: 11903-11912.
31. Wang J, Song Y, Zhang Y, Xiao H, Sun Q, Hou N, Guo S, Wang Y, Fan K, Zhan D, Zha L, Cao Y, Li Z, Cheng X, Yang X,. 2011. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res
32. Xu XD, Song XW, Li Q, Wang GK, Jing Q, Qin YW,. 2011. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy. J Cell Physiol 227: 1391-1398.
33. Yang CJ, Shen WG, Liu CJ, Chen YW, Lu HH, Tsai MM, Lin SC,. 2011. miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. J Oral Pathol Med 40: 560-566.
34. Yekta S, Shih IH, Bartel DP,. 2004. MicroRNA-directed cleavage of HOXB8 mRNA. Science 304: 594-596.